S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

BIAF bioAffinity Technologies Inc

0.7292

-0.0255 (-3.38%)

Last Updated: 03:18:55

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

bioAffinity Technologies (NASDAQ:BIAF)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more bioAffinity Technologies Charts.

bioAffinity Technologies (NASDAQ:BIAF)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more bioAffinity Technologies Charts.

bioAffinity Technologies Inc News

bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung
Tuesday 14 January 2025 (1 day ago) • Business Wire

Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19
Wednesday 18 December 2024 (4 weeks ago) • Business Wire

bioAffinity Technologies Set for Continued Expansion in 2025
Friday 13 December 2024 (1 month ago) • Business Wire

Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule
Friday 6 December 2024 (1 month ago) • Business Wire

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
Friday 15 November 2024 (2 months ago) • Business Wire

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
Tuesday 5 November 2024 (2 months ago) • Business Wire

bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
Wednesday 30 October 2024 (3 months ago) • Business Wire

WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement
Tuesday 22 October 2024 (3 months ago) • PR Newswire (US)

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement
Tuesday 22 October 2024 (3 months ago) • Business Wire

WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement
Saturday 19 October 2024 (3 months ago) • PR Newswire (US)

bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement
Saturday 19 October 2024 (3 months ago) • Business Wire

bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
Wednesday 16 October 2024 (3 months ago) • Business Wire

More bioAffinity Technologies Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions